Skip to content

Epidural Analgesia in Different Cervix Diameter and the Rate of Cesarean Delivery

Epidural Labor Analgesia in Different Cervical Dilation Diameter and the Risk of Cesarean Delivery

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00677274
Acronym
EACDRCD
Enrollment
780
Registered
2008-05-14
Start date
2008-05-31
Completion date
2008-08-31
Last updated
2009-02-12

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Labor Pain

Keywords

Epidural analgesia, Patient-controlled analgesia

Brief summary

Epidural analgesia in the early stage of labor at cervix \< 4.0cm was considered as a risk period for increasing the rate of cesarean delivery. The more recent studies and the investigators' previous data indicated epidural analgesia can be performed as early as the cervical dilation approximately 2.0cm. The investigators hypothesized that different cervix diameter had different rate of cesarean delivery. This trial would investigate the correlation amongst different cervical dilation and the risk of cesarean section in nulliparous women at term.

Interventions

PROCEDUREEpidural labor analgesia

Epidural analgesia initiated at the onset of regular uterine contraction

Sponsors

HRSA/Maternal and Child Health Bureau
CollaboratorFED
Nanjing Medical University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
QUADRUPLE (Subject, Caregiver, Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
FEMALE
Age
18 Years to 45 Years
Healthy volunteers
No

Inclusion criteria

1. Nulliparous women 2. \> 18 years and \< 45 years 3. Spontaneous labor 4. Analgesia request

Exclusion criteria

1. Allergy to opioids, a history of the use of centrally-acting drugs of any sort, chronic pain and psychiatric diseases records 2. Participants younger than 18 years or older than 45 years 3. Those who were not willing to or could not finish the whole study at any time 4. Using or used in the past 14 days of the monoamine oxidase inhibitors 5. Alcohol addictive or narcotic dependent patients were excluded for their influence on the analgesic efficacy of the epidural analgesics; 6. Subjects with a nonvertex presentation or scheduled induction of labor 7. Cervical dilation was 5.0cm or greater before performing epidural puncture and catheterization. 8. Diagnosed diabetes mellitus and pregnancy-induced hypertension 9. Twin gestation and breech presentation.

Design outcomes

Primary

MeasureTime frame
Rate of cesarean delivery10 min after successful vaginal delivery

Secondary

MeasureTime frame
Incidence of maternal side effects1 week after successful vaginal delivery
Rate of instrument-assisted delivery10 min after successful vaginal delivery
Indications of cesarean delivery10 min after cesarean section
Maternal Visual Analog Scale (VAS) rating of pain10 min prior to analgesia, at the cervix <4.0 cm, cervix 4.0-10.0 cm, cervix >10.0cm second stage of labor, 15min after vaginal delivery
Duration of analgesia0 min after analgesia to 15min after the disappearance of sensory block
Maternal satisfaction with analgesia30 min after the vaginal delivery
Maternal oral temperature0, 15, 30, 60, 120, 240, 480min after analgesia
Use of oxytocin after analgesia30 min after vaginal delivery
Maximal oxytocin dose30 min after vaginal delivery
Low back pain at 3 months after vaginal deliveryThree months after vaginal delivery
Breastfeeding success at 6 weeks after vaginal deliverySix weeks after successful delivery
Neonatal one-minute Apgar scale1 min after baby was born
Neonatal five-minute Apgar scaleFive min after baby was born
Umbilical-cord gases analysis0 min after baby was born
Neonatal sepsis evaluation30 min after baby was born
Neonatal antibiotic treatment1 week after baby was born

Countries

China

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Mar 8, 2026